Compare HELP & FC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HELP | FC |
|---|---|---|
| Founded | N/A | 1983 |
| Country | Canada | United States |
| Employees | 50 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.0M | 268.7M |
| IPO Year | N/A | 1994 |
| Metric | HELP | FC |
|---|---|---|
| Price | $5.65 | $23.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $51.50 | $26.00 |
| AVG Volume (30 Days) | ★ 1.0M | 257.3K |
| Earning Date | 07-01-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $267,067,000.00 |
| Revenue This Year | N/A | $3.15 |
| Revenue Next Year | N/A | $4.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.29 | $11.16 |
| 52 Week High | $8.55 | $24.70 |
| Indicator | HELP | FC |
|---|---|---|
| Relative Strength Index (RSI) | 57.24 | 73.09 |
| Support Level | $4.40 | $18.76 |
| Resistance Level | $8.55 | $24.38 |
| Average True Range (ATR) | 0.30 | 1.64 |
| MACD | 0.13 | 0.29 |
| Stochastic Oscillator | 79.09 | 86.42 |
Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland.
Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.